Direct Effects of Glucagon-Like Peptide-1 Receptor Ligands on Myocardial Function in Isolated Hearts from Streptozotocin-Induced Diabetic Rats

Abstract Purpose Glucagon-like peptide-1 (GLP-1) receptor ligands are widely used for the treatment of type 2 diabetes mellitus and obesity and have demonstrated cardioprotective effects beyond glycemic control. This study investigated the direct effects of GLP-1 receptor ligands and the dipeptidyl peptidase-4 inhibitor sitagliptin on myocardial function in isolated hearts from streptozotocin-induced diabetic rats. Methods Diabetes was induced in male Wistar rats by a single intraperitoneal injection of streptozotocin (50 mg/kg). Hearts from control and diabetic rats were retrogradely perfused for 30 min using a Langendorff system with GLP-1 (7–36), GLP-1 (9–36), exendin-4 (1–39), sitagliptin, glimepiride, pioglitazone, or metformin. Cardiac functional parameters, plasma total and active GLP-1 concentrations and serum total antioxidant status (TAS), total oxidant status (TOS), total sulfhydryl groups (TSG), advanced oxidation protein products (AOPP), and ischemia-modified albumin (IMA) were assessed. Results Diabetic hearts exhibited significantly lower heart rates and impaired left ventricular contractility and relaxation, indicated by reduced left ventricular + dP/dt max and -dP/dt min values, compared with controls. GLP-1 (7–36), GLP-1 (9–36), and exendin-4 (1–39) partially improved contractility and relaxation. Compared with controls, diabetic rats exhibited significantly higher plasma total and active GLP-1 concentrations, increased serum TOS and AOPP levels, and reduced TSG levels, whereas serum TAS and IMA levels remained unchanged. Conclusion These findings suggest that GLP-1 receptor ligands partially improve myocardial contractility and relaxation in isolated hearts from streptozotocin-induced diabetic rats, although the mechanisms underlying these effects remain to be elucidated.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-13
DOI
https://doi.org/10.21203/rs.3.rs-11561270/v1
Primary Topic
Diabetes Treatment and Management
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Direct Effects of Glucagon-Like Peptide-1 Receptor Ligands on Myocardial Function in Isolated Hearts from Streptozotocin-Induced Diabetic Rats

Gül Özbey, Cahit Nacıtarhan, Sebahat Özdem, Zinnet Şevval Aksoyalp et al.
Research Square
Diabetes Treatment and Management
preprint

Direct Effects of Glucagon-Like Peptide-1 Receptor Ligands on Myocardial Function in Isolated Hearts from Streptozotocin-Induced Diabetic Rats

Gül Özbey, Cahit Nacıtarhan, Sebahat Özdem, Zinnet Şevval Aksoyalp, Esra Akcabag, Feride Öner, Arda Taşatargil, Sadi S. Özdem, Zeliha Bayram
preprint en

Abstract

Abstract Purpose Glucagon-like peptide-1 (GLP-1) receptor ligands are widely used for the treatment of type 2 diabetes mellitus and obesity and have demonstrated cardioprotective effects beyond glycemic control. This study investigated the direct effects of GLP-1 receptor ligands and the dipeptidyl peptidase-4 inhibitor sitagliptin on myocardial function in isolated hearts from streptozotocin-induced diabetic rats. Methods Diabetes was induced in male Wistar rats by a single intraperitoneal injection of streptozotocin (50 mg/kg). Hearts from control and diabetic rats were retrogradely perfused for 30 min using a Langendorff system with GLP-1 (7–36), GLP-1 (9–36), exendin-4 (1–39), sitagliptin, glimepiride, pioglitazone, or metformin. Cardiac functional parameters, plasma total and active GLP-1 concentrations and serum total antioxidant status (TAS), total oxidant status (TOS), total sulfhydryl groups (TSG), advanced oxidation protein products (AOPP), and ischemia-modified albumin (IMA) were assessed. Results Diabetic hearts exhibited significantly lower heart rates and impaired left ventricular contractility and relaxation, indicated by reduced left ventricular + dP/dt max and -dP/dt min values, compared with controls. GLP-1 (7–36), GLP-1 (9–36), and exendin-4 (1–39) partially improved contractility and relaxation. Compared with controls, diabetic rats exhibited significantly higher plasma total and active GLP-1 concentrations, increased serum TOS and AOPP levels, and reduced TSG levels, whereas serum TAS and IMA levels remained unchanged. Conclusion These findings suggest that GLP-1 receptor ligands partially improve myocardial contractility and relaxation in isolated hearts from streptozotocin-induced diabetic rats, although the mechanisms underlying these effects remain to be elucidated.

Research Square
Akdeniz University (TR)
Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
Good health and well-being
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon